Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice
Introduction
The hallmark phenomena in inbred MRL/MpJ-lpr (MRL-lpr) and MRL/MpJ +/+ (MRL +/+) murine substrains are hypermaturity, accelerated aging and spontaneous development of a systemic, lupus-like autoimmune disease (Smith and Steinberg, 1983). Although MRL-lpr and MRL +/+ mice are similar in many respects (e.g., appearance, size and reproductive age), they differ in the age of onset of autoimmunity. MRL-lpr mice show lupus-like symptoms between the 2nd and the 3rd month of life whereas MRL +/+ mice show them several months later (reviewed in the work of Theofilopoulos (1992)). The principal factor accounting for the accelerated autoimmunity in the MRL-lpr substrain is a defect in Fas gene expression, produced by a point mutation in the lpr gene on chromosome 19 (reviewed in the work of Shirai and Klinman (1994)). This mutation interferes with normal Fas-induced apoptosis, and so contributes to prolonged survival of activated lymphocytes and autoreactive T- and B-cell clones.
Coincident with the appearance of serological indices of autoimmunity MRL-lpr mice develop a characteristic behavioral syndrome, which we labeled `autoimmunity-associated behavioral syndrome' (AABS), a constellation of behavioral alterations found in the MRL-lpr, in contrast to the MRL +/+, substrain (Šakić et al., 1997b). This syndrome in MRL-lpr mice resembles behavioral changes induced by chronic, inescapable stress (reviewed in the work of Anisman and Zacharko (1990)), as reflected by diminished exploration of novel objects and space, excessive floating in the forced swim test, reduced responsiveness to sucrose, perseveration on reversal learning, poor active avoidance learning, reduced aggressiveness, and increased `anxiety' (reviewed in the work of Šakić et al. (1997b) and Szechtman et al. (1997)). Most of the behavioral symptoms appear before overt signs of autoimmune disease, such as generalized lymphadenopathy, dermatitis, joint pathology, or glomerulonephritis. Some behavioral symptoms can be prevented by early immunosuppressive treatment with cyclophosphamide (Šakić et al., 1995Šakić et al., 1996), supporting the suggestion that autoimmune/inflammatory factors induce AABS.
Attempts to identify changes in brain morphology related to AABS failed to identify either cerebral vasculopathic or ischemic lesions in MRL-lpr mice (Hess et al., 1993), as might be expected on the basis of neuropathologic studies of human neuropsychiatric lupus (Johnson and Richardson, 1968; Ellis and Verity, 1979), or the cortical ectopias, as observed in other autoimmune strains (Sherman et al., 1987, Sherman et al., 1988, Sherman et al., 1990). About 50% of MRL-lpr mice posses enlarged ventricles (Denenberg et al., 1992), but it is not known whether this is also characteristic of the MRL +/+ substrain. The only consistent neuropathologic finding which may account for AABS is the presence of large clusters of T- and B-cells in the choroid plexus and brain parenchyma of MRL-lpr mice (Alexander et al., 1983; Vogelweid et al., 1991; Hess et al., 1993; Farrell et al., 1997). In light of such findings, and following our notion that AABS resembles the effects of chronic stress (Šakić et al., 1992), we reasoned that structural brain changes in MRL-lpr mice would be of the kind observed after chronic stress. Neuronal dendrites are one of the most plastic structural brain elements, undergoing growth or atrophy in response to such diverse manipulations as stress (Magarinos and McEwen, 1995), learning (Comery et al., 1995), circulating hormones (Magarinos and McEwen, 1995), and lesions (Kolb et al., 1997a) Consequently, in the present study we compared dendritic morphology of diseased MRL-lpr mice and MRL +/+ controls at two ages: at 5 weeks of age, when few serologic signs of lupus disease are recognizable; and at 14 weeks of age, when the disease is florid (Šakić et al., 1993Šakić et al., 1994). We expected to see little difference between the substrains at an early age, but dendritic atrophy in MRL-lpr mice at a later age. The sensorimotor parietal cortex and the CA1 field of the hippocampus were chosen for this analysis because behavior-related dendritic changes in these areas had been observed previously (Lolova, 1989; Kolb and Gibb, 1991).
Section snippets
Animals
Three-week old (±3 days) MRL-lpr and MRL +/+ males (n=6 mice/substrain) of a similar body weight were purchased from the Jackson Laboratory (Bar Harbor, ME) and housed singly, under standard laboratory conditions (light phase: 8 AM–8 PM). Three mice from each substrain were sacrificed at 5 or 14 weeks of age. In one 14-week old MRL-lpr mouse the hippocampal region was not examined due to damage during the fixation/preparation period.
Golgi stain and analysis
Mice were anesthetized with isofluorene and transcardially
Results
As shown in Fig. 1, the brain weight of 14-week old MRL-lpr male mice was significantly lower than that of age-matched MRL +/+ controls (0.668±0.012 vs. 0.728±0.013 g, t(4)=3.454, p=0.026); brain weight of the younger (5 weeks old) MRL-lpr animals was not statistically different from controls (0.654±0.015 vs. 0.676±0.022 g). In contrast to brain weight, the body weight of MRL-lpr mice was not statistically different from that of MRL +/+ males, either at 14 weeks (47.6±1.5 g vs. 49.7±1.6 g) or 5
Discussion
The present study found a shrinkage of dendritic arborization and loss of dendritic spines in parietal and hippocampal pyramidal neurons of MRL-lpr mice. This atrophy showed relative selectivity for basilar vs. apical dendrites; was relatively large in magnitude; was evident from the earliest age examined; and had an age/disease-related course. These four aspects of dendritic atrophy are discussed below in reverse order.
The number of basilar dendrite branches in the parietal cortex of MRL-lpr
Acknowledgements
B.S. was a post-doctoral fellow of the Ontario Mental Health Foundation. H.S. is a Research Associate of the Ontario Mental Health Foundation. Supported in part by funds from NSERC, Lupus Foundation of Ontario, Lupus Society of Hamilton, and Ontario Lupus Association.
References (62)
- et al.
Multiple neurochemical and behavioral consequences of stressors: implications for depression
Pharmacol. Ther.
(1990) - et al.
Differential rearing alters spine density on medium-sized spiny neurons in the rat corpus striatum: evidence for association of morphological plasticity with early response gene expression
Neurobiol. Learn. Mem.
(1995) - et al.
A behavior profile of the MRL/Mp lpr/lpr mouse and its association with hydrocephalus
Brain Behav. Immun.
(1992) - et al.
Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955–1977
Semin. Arthritis Rheum.
(1979) - et al.
Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development
Brain Res.
(1994) - et al.
Sparing of function after neonatal frontal lesions correlates with increased cortical dendritic branching: a possible mechanism for the Kennard effect
Behav. Brain Res.
(1991) - et al.
Nerve growth factor treatment prevents dendritic atrophy and promotes recovery of function after cortical injury
Neuroscience
(1997) - et al.
Disturbed immunoendocrine communication via the hypothalamo–pituitary–adrenal axis in murine lupus
Brain Behav. Immun.
(1996) - et al.
Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors
Neuroscience
(1995) - et al.
Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats
Biochem. Biophys. Res. Commun.
(1988)
Immunoregulators in the nervous system
Neurosci. Biobehav. Rev.
Developmental expression of cytokine genes in the cortex and hippocampus of the rat central nervous system
Dev. Brain Res.
A behavioral profile of autoimmune lupus-prone MRL mice
Brain Behav. Immun.
Spatial learning during the course of autoimmune disease in MRL mice
Behav. Brain Res.
Behavior and immune status of MRL mice in the postweaning period
Brain Behav. Immun.
Immunosuppressive treatment prevents behavioral deficit in autoimmune MRL-lpr mice
Physiol. Behav.
Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study
Brain Res. Bull.
Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6
Brain Res. Bull.
Neurobehavioral alteration in autoimmune mice
Neurosci. Biobehav. Rev.
Progressive dendritic changes in aging human cortex
Exp. Neurol.
Gene expression and function of interleukin-1, interleukin-6 and tumor necrosis factor in the brain
Prog. Neurobiol.
Brain abnormalities in immune defective mice
Brain Res.
Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice
Brain Res.
Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings
J. Neuroimmunol.
Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons
Brain Res.
Congenic autoimmune murine models of central nervous system disease in connective tissue disorders
Ann. Neurol.
Age and hemisphere effects on dendritic structure
Brain
Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6
Proc. Natl. Acad. Sci. USA
Environmental effects on cortical dendritic fields: I. Rearing in the dark
J. Anat.
Dendritic pathology of granule cells in Alzheimer's disease is unrelated to neuritic plaques
J. Neurosci.
Cited by (81)
Cognitive dysfunction in SLE: An understudied clinical manifestation
2022, Journal of AutoimmunityProbing Caffeine Administration as a Medical Management for Hydrocephalus: An Experimental Study
2022, Pediatric NeurologyThe brain in SLE: Mechanisms and detection of injury and therapeutic strategies
2021, Lahita’s Systemic Lupus ErythematosusAn inducible system for in vitro and in vivo Fas activation using FKBP-FRB-rapamycin complex
2020, Biochemical and Biophysical Research CommunicationsCitation Excerpt :Consequently, Fas activation could trigger non-apoptotic, mitogenic signaling pathways through ERK, c-Jun N-terminal protein kinases (JNK) and NFκB, leading to cell proliferation [4]. Studies regarding Fas signaling pathway had been mostly conducted by treating Fas ligand or studying Fas ligand/Fas receptor knockout mice [5]. Lack of precisely controllable platform had hampered the study of sophisticated Fas signaling.
Pathogenesis of tissue injury in the brain in patients with systemic lupus erythematosus
2020, Systemic Lupus Erythematosus: Basic, Applied and Clinical AspectsCNS Macrophages Control Neurovascular Development via CD95L
2017, Cell Reports